Cargando…
Treatment Response Biomarkers in Asthma and COPD
Chronic obstructive pulmonary disease (COPD) and asthma are two of the most common chronic diseases worldwide. Both diseases are heterogenous and complex, and despite their similarities, they differ in terms of pathophysiological and immunological mechanisms. Mounting evidence supports the presence...
Autores principales: | Meteran, Howraman, Sivapalan, Pradeesh, Stæhr Jensen, Jens-Ulrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464838/ https://www.ncbi.nlm.nih.gov/pubmed/34574009 http://dx.doi.org/10.3390/diagnostics11091668 |
Ejemplares similares
-
Recent developments in the management of severe asthma
por: Meteran, Howraman, et al.
Publicado: (2022) -
The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
por: Jordan, Alexander, et al.
Publicado: (2021) -
Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
por: Bonnesen, Barbara, et al.
Publicado: (2022) -
Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
por: Sivapalan, Pradeesh, et al.
Publicado: (2021) -
Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method
por: Jordan, Alexander, et al.
Publicado: (2023)